PATENT CLAIM ANALYSIS

Application Number: 16006526
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 107):
The method of  claim 105 , wherein at least 80% of the uracil in the open reading frame of (a)-(f) have a chemical modification selected from 1-methyl-pseudouridine or 1-ethyl-pseudouridine.

Metadata:
- Claim Count in Document: 79.0
- Percentile: 94.0
- Lexical Diversity: 1.19048
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15674569', '15001825', '14815162', '14949161', '14973409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7635142263881799
- 35 USC 102 Novelty (BERT): 0.7594562939330106
- Combined Prediction Score: 0.763108433142663
- Mean Citation Score: 598.9896759999998
- Max Citation Score: 1014.46155
- Similarity Product: 858.6338692904413

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test